RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Phibro Animal Health Stock

Phibro Animal Health P/E 2024

Phibro Animal Health P/E

300.74

Ticker

PAHC

ISIN

US71742Q1067

WKN

A1WZ6P

As of Sep 29, 2024, Phibro Animal Health's P/E ratio was 300.74, a 1,773.77% change from the 16.05 P/E ratio recorded in the previous year.

The Phibro Animal Health P/E history

Phibro Animal Health Aktienanalyse

What does Phibro Animal Health do?

Phibro Animal Health Corp is a globally leading company specializing in the research, development, production, and marketing of animal health products. The company was founded in 1947 and is headquartered in Teaneck, New Jersey, USA. The company originally produced additives and aids for the food industry but recognized the potential of the animal health market in the 1950s and shifted its focus to developing and marketing animal health products. In the 1970s, the company introduced the first antibiotic for agricultural animals. Phibro Animal Health Corp's business model is to manufacture innovative animal health products and sell them to livestock owners, veterinarians, agricultural farms, and other customers worldwide. The company aims to improve the quality of life and production conditions of livestock by focusing on the prevention and treatment of diseases and infections. Phibro Animal Health Corp has two main business segments: Animal Health and Performance. In the Animal Health segment, the company offers products for the prevention and treatment of diseases in livestock such as pigs, poultry, cattle, and fish. These products include vaccines, antibiotics, other medications, as well as feed additives and disinfectants. In the Performance segment, the company offers feed additives and special minerals that are designed to improve the performance and health of livestock. Some of the company's key products include Amprolium, an antibiotic for the treatment of coccidiosis commonly found in poultry; Autogenous Vaccines, customized vaccines tailored to the specific needs of a farm for higher effectiveness; Salinomycin, an antibiotic for the prevention of coccidiosis in poultry; COOL-AID, a feed additive that lowers the body temperature of livestock to improve their well-being; and X-Zelit, a mineral feed additive that enhances phosphorus absorption in dairy cows and increases milk production. Phibro Animal Health Corp operates in over 60 countries, serving livestock owners and agricultural farms worldwide. The company is committed to developing innovative products that contribute to improving the quality of life for livestock and increasing the productivity and profitability of agricultural farms. Phibro Animal Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Phibro Animal Health's P/E Ratio

The Price to Earnings (P/E) Ratio of Phibro Animal Health is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Phibro Animal Health's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Phibro Animal Health is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Phibro Animal Health’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Phibro Animal Health stock

What is the price-to-earnings ratio of Phibro Animal Health?

The price-earnings ratio of Phibro Animal Health is currently 300.74.

How has the price-earnings ratio of Phibro Animal Health changed compared to last year?

The price-to-earnings ratio of Phibro Animal Health has increased by 1,773.77% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Phibro Animal Health high compared to other companies?

Yes, the price-to-earnings ratio of Phibro Animal Health is high compared to other companies.

How does an increase in the price-earnings ratio of Phibro Animal Health affect the company?

An increase in the price-earnings ratio of Phibro Animal Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Phibro Animal Health affect the company?

A decrease in the price-earnings ratio of Phibro Animal Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Phibro Animal Health?

Some factors that influence the price-earnings ratio of Phibro Animal Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Phibro Animal Health pay?

Over the past 12 months, Phibro Animal Health paid a dividend of 0.36 USD . This corresponds to a dividend yield of about 1.63 %. For the coming 12 months, Phibro Animal Health is expected to pay a dividend of 0.4 USD.

What is the dividend yield of Phibro Animal Health?

The current dividend yield of Phibro Animal Health is 1.63 %.

When does Phibro Animal Health pay dividends?

Phibro Animal Health pays a quarterly dividend. This is distributed in the months of December, April, July, October.

How secure is the dividend of Phibro Animal Health?

Phibro Animal Health paid dividends every year for the past 0 years.

What is the dividend of Phibro Animal Health?

For the upcoming 12 months, dividends amounting to 0.4 USD are expected. This corresponds to a dividend yield of 1.81 %.

In which sector is Phibro Animal Health located?

Phibro Animal Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Phibro Animal Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Phibro Animal Health from 9/25/2024 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/4/2024.

When did Phibro Animal Health pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of Phibro Animal Health in the year 2023?

In the year 2023, Phibro Animal Health distributed 0.48 USD as dividends.

In which currency does Phibro Animal Health pay out the dividend?

The dividends of Phibro Animal Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Phibro Animal Health

Our stock analysis for Phibro Animal Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Phibro Animal Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.